Skip to main content
. 2023 Oct 7;28(19):6962. doi: 10.3390/molecules28196962

Figure 8.

Figure 8

IVIVC processing DGIM vs. USPII: (A) in vivo fraction of absorption in DGIM vs. USP II; (B) in vivo fraction of absorption; and (C) the observed ketoconazole plasma concentration and the predicted ketoconazole plasma concentration–time profiles.